Guardant Health, Inc. (GH) financial statements (2020 and earlier)

Company profile

Business Address 505 PENOBSCOT DR.
REDWOOD CITY, CA 94063
State of Incorp. DE
Fiscal Year End December 31
SIC 8071 - Medical Laboratories (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

9/30/2019
TTM
12/31/2018
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments523419
Cash and cash equivalents147141
Short-term investments376278
Receivables4036
Inventory, net of allowances, customer advances and progress billings159
Inventory159
Other undisclosed current assets65
Total current assets:583469
Noncurrent Assets
Property, plant and equipment4131
Long-term investments and receivables30378
Long-term investments30378
Intangible assets, net (including goodwill)12 
Goodwill3 
Intangible assets, net (excluding goodwill)9 
Other noncurrent assets32
Other undisclosed noncurrent assets78
Total noncurrent assets:365118
TOTAL ASSETS:948587
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities2918
Accounts payable1211
Accrued liabilities177
Debt00
Deferred compensation liability2513
Deferred rent credit1 
Other undisclosed current liabilities1316
Total current liabilities:6847
Noncurrent Liabilities
Long-term debt and lease obligation00
Capital lease obligations00
Liabilities, other than long-term debt128
Deferred rent credit118
Other liabilities10
Other undisclosed noncurrent liabilities77
Total noncurrent liabilities:1916
Total liabilities:8662
Temporary equity, carrying amount4742
Stockholders' equity
Stockholders' equity attributable to parent, including:815483
Additional paid in capital1,142764
Accumulated other comprehensive income (loss)1(0)
Accumulated deficit(328)(281)
Other undisclosed stockholders' equity attributable to parent00
Total stockholders' equity:815483
TOTAL LIABILITIES AND EQUITY:948587

Income statement (P&L) ($ in millions)

9/30/2019
TTM
12/31/2018
Revenues18491
Cost of revenue(58)(42)
Gross profit:12649
Operating expenses(210)(142)
Operating loss:(84)(93)
Nonoperating income1310
Investment income, nonoperating125
Other nonoperating income05
Interest and debt expense(1)(1)
Loss from continuing operations before income taxes:(72)(84)
Income tax expense (benefit)1(0)
Net loss:(71)(84)
Net loss attributable to noncontrolling interest(5)(1)
Net loss attributable to parent:(76)(85)
Preferred stock dividends and other adjustments (1)
Other undisclosed net income available to common stockholders, basic 1
Net loss available to common stockholders, diluted:(76)(85)

Comprehensive Income ($ in millions)

9/30/2019
TTM
12/31/2018
Net loss:(71)(84)
Other comprehensive income20
Comprehensive loss:(69)(84)
Comprehensive loss, net of tax, attributable to noncontrolling interest(5)(1)
Comprehensive loss, net of tax, attributable to parent:(74)(85)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: